EdgeMarketInstruments › SDGR

SDGR — Schrodinger, Inc.

US Healthcare Pharma & biotech equity mkt cap 1.4B
19.71 +0.66% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 11.07 · high 22.52

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2020-02-06.

Performance

1 day+0.66%
1 week+12.05%
1 month+30.27%
3 months+48.98%
6 months+70.95%
Year to date+9.62%
1 year+1.81%
3 years-43.18%
5 years-66.96%

Technicals

RSI 1478.7
vs 50-day avg+20.33%
vs 200-day avg+31.26%
Volatility 1y53.6%
Max drawdown 1y-50.84%
Avg volume 30d1.1M
Daily bars held1,644
History from2020-02-06

Measured signals that fired on SDGR

datesignal measured base rate
2026-08-17Fair value gap, bearish
structure
-0.45% over 21 days · t = -3.29 · n = 108,591
statistically distinguishable from its control group
2026-08-06Equal highs taken out
structure
-0.70% over 21 days · t = -8.28 · n = 68,636
statistically distinguishable from its control group
2026-08-06Fair value gap, bullish
structure
-0.67% over 21 days · t = -6.43 · n = 111,973
statistically distinguishable from its control group
2026-06-30Equal highs taken out
structure
-0.70% over 21 days · t = -8.28 · n = 68,636
statistically distinguishable from its control group
2026-05-22Equal highs taken out
structure
-0.70% over 21 days · t = -8.28 · n = 68,636
statistically distinguishable from its control group
2026-04-23Fair value gap, bearish
structure
-0.45% over 21 days · t = -3.29 · n = 108,591
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-07-16Jain Rachit
EVP & CFO
Open-market sale 10b5-1 plan87515.6013.6K
2026-06-26Friesner Richard
Director
Gift679.4K0.000
2026-06-26Friesner Richard
Director
Gift679.4K0.000
2026-06-22GINSBERG GARY L
Director
Grant or award8.1K0.000
2026-06-22van Kralingen Bridget A
Director
Grant or award8.1K0.000
2026-06-22Kapeller-Libermann Rosana
Director
Grant or award8.1K0.000
2026-06-22OBEROI ARUN
Director
Grant or award8.1K0.000
2026-06-22Lynton Michael
Director
Grant or award8.1K0.000
2026-06-22Friesner Richard
Director
Grant or award8.1K0.000
2026-06-22Chodakewitz Jeffrey
Director
Grant or award8.1K0.000

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
BlackRock, Inc.109.9M9.7M
GATES FOUNDATION TRUST79.3M7.0M
Rubric Capital Management LP68.2M6.0M
VANGUARD PORTFOLIO MANAGEMENT LLC43.9M3.9M
Amova Asset Management Americas, Inc.36.2M3.2M
Sumitomo Mitsui Trust Group, Inc.36.2M3.2M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/30.5M2.7M
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC30.2M2.7M
VANGUARD CAPITAL MANAGEMENT LLC29.6M2.6M
STATE STREET CORP24.9M2.2M

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Short selling

Avg short volume, 90d47.3% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about SDGR

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open SDGR in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →